IL40521A - 1-heterocyclyl-3-indolealkanoic acid derivatives - Google Patents

1-heterocyclyl-3-indolealkanoic acid derivatives

Info

Publication number
IL40521A
IL40521A IL40521A IL4052172A IL40521A IL 40521 A IL40521 A IL 40521A IL 40521 A IL40521 A IL 40521A IL 4052172 A IL4052172 A IL 4052172A IL 40521 A IL40521 A IL 40521A
Authority
IL
Israel
Prior art keywords
heterocyclyl
acid derivatives
indolealkanoic
indolealkanoic acid
derivatives
Prior art date
Application number
IL40521A
Other languages
English (en)
Other versions
IL40521A0 (en
Original Assignee
Ici Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ici Ltd filed Critical Ici Ltd
Publication of IL40521A0 publication Critical patent/IL40521A0/xx
Publication of IL40521A publication Critical patent/IL40521A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D209/26—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with an acyl radical attached to the ring nitrogen atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
IL40521A 1971-11-03 1972-10-06 1-heterocyclyl-3-indolealkanoic acid derivatives IL40521A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB1811672A GB1356834A (en) 1971-11-03 1971-11-03 Indole derivatives
GB1811672 1972-04-19
GB3076772 1972-06-30

Publications (2)

Publication Number Publication Date
IL40521A0 IL40521A0 (en) 1972-12-29
IL40521A true IL40521A (en) 1975-06-25

Family

ID=27257588

Family Applications (1)

Application Number Title Priority Date Filing Date
IL40521A IL40521A (en) 1971-11-03 1972-10-06 1-heterocyclyl-3-indolealkanoic acid derivatives

Country Status (17)

Country Link
US (1) US3884919A (2)
JP (1) JPS4856667A (2)
AR (3) AR198064A1 (2)
BE (1) BE790679A (2)
CA (1) CA983932A (2)
CH (1) CH577499A5 (2)
DD (1) DD105611A5 (2)
DE (1) DE2253927A1 (2)
EG (1) EG11358A (2)
ES (2) ES408226A1 (2)
FR (1) FR2158464B1 (2)
GB (1) GB1356834A (2)
HU (1) HU169711B (2)
IE (1) IE37998B1 (2)
IL (1) IL40521A (2)
NL (1) NL7214807A (2)
SE (1) SE384856B (2)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4022780A (en) * 1973-03-06 1977-05-10 Imperial Chemical Industries Limited Process for the manufacture of indole derivatives
FR2421900A1 (fr) * 1977-03-17 1979-11-02 Sauba Lab Piperazino-3-indoles, leur procede de preparation et leurs applications therapeutiques
US4316847A (en) * 1979-07-30 1982-02-23 Hoffmann-La Roche Inc. Pyrroles and pyrrolidines
US4459227A (en) * 1981-03-02 1984-07-10 Duke University Para-hydroxyphenylhydrazines as in situ precursors of iminoquinones and quinones
BR9506936A (pt) * 1994-02-23 1997-09-09 Pfizer Derivados de quinazolina substituídos com 4-heterociclila processos para sua preparaçao e seu uso como agentes anticancerosos
US6252084B1 (en) * 1994-03-15 2001-06-26 Eli Lilly And Company 1H-indole-3-acetamide sPLA2 inhibitors
EE200000488A (et) * 1998-02-25 2002-02-15 Genetics Institute, Inc. Fosfolipaasensüümide inhibiitorid ja farmatseutilised kompositsioonid
US6500853B1 (en) 1998-02-28 2002-12-31 Genetics Institute, Llc Inhibitors of phospholipase enzymes
SE0200411D0 (sv) * 2002-02-05 2002-02-05 Astrazeneca Ab Novel use
SE0200356D0 (sv) * 2002-02-05 2002-02-05 Astrazeneca Ab Novel use
TW200307542A (en) 2002-05-30 2003-12-16 Astrazeneca Ab Novel compounds
SE0201635D0 (sv) 2002-05-30 2002-05-30 Astrazeneca Ab Novel compounds
SE0202241D0 (sv) 2002-07-17 2002-07-17 Astrazeneca Ab Novel Compounds
SE0301010D0 (sv) * 2003-04-07 2003-04-07 Astrazeneca Ab Novel compounds
SE0301009D0 (sv) * 2003-04-07 2003-04-07 Astrazeneca Ab Novel compounds
DE60303238T2 (de) 2003-04-25 2006-09-14 Actimis Pharmaceuticals, Inc., La Jolla Pyrimidin-Essigsäure Derivate geeignet zur Behandlung von CRTH2-bedingten Krankheiten
CA2524221A1 (en) * 2003-04-30 2004-11-18 The Institutes For Pharmaceutical Discovery, Llc Substituted heteroaryls as inhibitors of protein tyrosine phosphatases
SE0301569D0 (sv) 2003-05-27 2003-05-27 Astrazeneca Ab Novel compounds
SE0302232D0 (sv) * 2003-08-18 2003-08-18 Astrazeneca Ab Novel Compounds
SA04250253B1 (ar) 2003-08-21 2009-11-10 استرازينيكا ايه بي احماض فينوكسي اسيتيك مستبدلة باعتبارها مركبات صيدلانية لعلاج الامراض التنفسية مثل الربو ومرض الانسداد الرئوي المزمن
GB0324763D0 (en) 2003-10-23 2003-11-26 Oxagen Ltd Use of compounds in therapy
SE0303180D0 (sv) 2003-11-26 2003-11-26 Astrazeneca Ab Novel compounds
CA2551778C (en) 2004-01-31 2013-10-22 Actimis Pharmaceuticals, Inc. Imidazo[1,2-c]pyrimidinylacetic acid derivatives
GB0415320D0 (en) 2004-07-08 2004-08-11 Astrazeneca Ab Novel compounds
GB0418830D0 (en) 2004-08-24 2004-09-22 Astrazeneca Ab Novel compounds
JP5208510B2 (ja) 2004-11-23 2013-06-12 アストラゼネカ・アクチエボラーグ 呼吸器疾患の処置に有用なフェノキシ酢酸誘導体
GB0500604D0 (en) 2005-01-13 2005-02-16 Astrazeneca Ab Novel process
TW200745003A (en) 2005-10-06 2007-12-16 Astrazeneca Ab Novel compounds
US8148572B2 (en) 2005-10-06 2012-04-03 Astrazeneca Ab Compounds
CN101454284A (zh) 2006-05-26 2009-06-10 阿斯利康(瑞典)有限公司 联芳基或芳基-杂芳基取代的吲哚类化合物
US7999119B2 (en) 2006-07-22 2011-08-16 Oxagen Limited Compounds having CRTH2 antagonist activity
UA100983C2 (ru) 2007-07-05 2013-02-25 Астразенека Аб Бифенилоксипропановая кислота как модулятор crth2 и интермедиаты
ATE547407T1 (de) 2007-09-25 2012-03-15 Actimis Pharmaceuticals Inc Alkylthiopyrimidine als crth2-antagonisten
WO2009042139A1 (en) 2007-09-25 2009-04-02 Actimis Pharmaceuticals, Inc. 2-s-benzyl substituted pyrimidines as crth2 antagonists
US7750027B2 (en) 2008-01-18 2010-07-06 Oxagen Limited Compounds having CRTH2 antagonist activity
AU2009204700B2 (en) 2008-01-18 2013-07-04 Atopix Therapeutics Limited Compounds having CRTH2 antagonist activity
EP2265581A1 (en) 2008-01-22 2010-12-29 Oxagen Limited Compounds having crth2 antagonist activity
JP2011509991A (ja) 2008-01-22 2011-03-31 オキサジェン リミテッド Ｃｒｔｈ２アンタゴニスト活性を有する化合物
GB201322273D0 (en) 2013-12-17 2014-01-29 Atopix Therapeutics Ltd Process
GB201407807D0 (en) 2014-05-02 2014-06-18 Atopix Therapeutics Ltd Polymorphic form
GB201407820D0 (en) 2014-05-02 2014-06-18 Atopix Therapeutics Ltd Polymorphic form
JOP20210060A1 (ar) * 2018-10-05 2023-01-30 Vertex Pharma معدلات لمضاد تريبسين ألفا-1

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL125443C (2) * 1963-06-06
US3679692A (en) * 1969-10-01 1972-07-25 Mead Johnson & Co Iminomethylindolines

Also Published As

Publication number Publication date
ES437311A1 (es) 1977-04-01
AR198064A1 (es) 1974-05-31
IL40521A0 (en) 1972-12-29
SE384856B (sv) 1976-05-24
US3884919A (en) 1975-05-20
JPS4856667A (2) 1973-08-09
CA983932A (en) 1976-02-17
NL7214807A (2) 1973-05-07
GB1356834A (en) 1974-06-19
FR2158464A1 (2) 1973-06-15
EG11358A (en) 1977-02-28
AR203626A1 (es) 1975-09-30
HU169711B (2) 1977-02-28
DE2253927A1 (de) 1973-05-10
IE37998L (en) 1973-05-03
AR203627A1 (es) 1975-09-30
FR2158464B1 (2) 1976-07-02
ES408226A1 (es) 1976-02-01
DD105611A5 (2) 1974-05-05
CH577499A5 (2) 1976-07-15
BE790679A (fr) 1973-04-27
IE37998B1 (en) 1977-12-07

Similar Documents

Publication Publication Date Title
IL40521A (en) 1-heterocyclyl-3-indolealkanoic acid derivatives
IL38605A0 (en) P-methane-carboxamide derivatives
IE36079L (en) Benzazine derivatives
HK2679A (en) 3-substituted-morphinan derivatives
IL39376A0 (en) Prostanoic acid derivatives
KE2731A (en) Oxidazolone derivatives
AU4847172A (en) Cycloalkylaminoarylcarboxylic acid derivatives
ZA728402B (en) Citric acid derivatives
ZA728401B (en) Citric acid derivatives
CA957371A (en) Carbamoyl-triiodophenoxy-ethoxy-propionic acid derivatives
IE37237L (en) Pyrroleacetic acid derivatives
IL39880A0 (en) 2-nitro-5-imidazolaldehyde derivatives
ZA728403B (en) Citric acid derivatives
IL38936A0 (en) Lumilysergol derivatives
ZA723158B (en) 2-p-nitro-or p-chlorobenzamidoaceto-hydroxamic acid
MY7500276A (en) 2-chloroethanephosphonic acid derivatives
CA967161A (en) Piperidine-acetic acid derivatives
PH9500A (en) 6-amino-penicillanic acid derivatives
GB1408201A (en) Adenosine-5-carboxylate derivatives
CY908A (en) Triazolyl-ethenyl-phenylene derivatives
GB1405794A (en) Alpha-thioacetic acid derivatives
GB1402325A (en) Dibenzoxirenoazepine derivatives
IE37196L (en) Diphenylpyrazolium derivatives
IL39834A (en) Beta-phenyl-beta-fluoroethane derivatives
MY7900211A (en) 2-aminomethylphenol derivatives